MRI在前列腺癌主动监测中的作用:现状
本文为叙述性综述,更新多参数MRI在前列腺癌主动监测中的应用,重点介绍PI-RADS v2.1、PI-QUAL v2与PRECISE v2的标准化采集、报告及风险分层意义。分析选择标准、12-24个月随访方案、影像质量参数与再活检的影像学触发因素。结论认为标准化整合MRI能改善监测结构化,但不能替代计划性活检。
要点
- 基线mpMRI可改善主动监测候选者选择,降低低估临床有意义疾病的风险。
- 影像学进展的敏感度约59%、特异度约75%,阴性预测值高(81-88%)但阳性预测值中等。
- PRECISE v2要求整合影像质量评估并与既往检查系统比较,提高可重复性与可比性。
核心结论
- 标准化整合mpMRI、PI-QUAL v2与PRECISE v2可实现更结构化的患者监测并支持多学科决策。
- mpMRI不能替代计划性活检,影像组学与人工智能可能进一步提高主动监测的客观性与有效性。
研究设计与样本
- 叙述性综述,回顾文献及最新国际指南中主动监测患者使用mpMRI的内容。
- 分析了选择标准、12-24个月随访方案、PI-QUAL v2影像质量参数与PRECISE v2纵向评估系统。
- 分析了再活检及多学科讨论的主要影像学触发因素。
关键影像表现/征象
- 基线mpMRI改善候选者选择并降低低估临床有意义疾病的风险。
- 随访中影像学进展的阴性预测值为81-88%,阳性预测值中等。
诊断标准与关键数值
- 影像学进展用于随访时敏感度约59%,特异度约75%。
- PRECISE v2引入更新分类,强制整合影像质量评估,并要求与既往检查系统比较。
临床应用与阅片要点
- 日常阅片应按PI-RADS v2.1进行标准化采集与报告,并评估影像质量为PI-QUAL v2。
- 随访中需系统比较当前与既往影像,依据PRECISE v2分类判断影像学进展。
- 识别可能触发再活检和多学科讨论的影像学征象。
- 注意mpMRI不能替代计划性活检,影像学进展阳性预测价值有限。
局限性
- 叙述性综述,未报告系统检索策略及纳入文献质量评价。
- 未报告样本量、设备与序列细节,影像学进展的敏感度和特异度未给出原始研究来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
POURPOSE: To provide an update on the role of multiparametric magnetic resonance imaging (mpMRI) in active surveillance (AS) of prostate cancer, with particular focus on standardizing image acquisition and reporting through PI-RADS v2.1, PI-QUAL v2, and PRECISE v2, as well as their clinical implications in risk stratification and follow-up.
MATERIALS AND METHODS: Narrative review of the literature and the most recent international guidelines on the use of mpMRI in patients undergoing AS. Selection criteria, follow-up protocols (12-24 months), imaging quality parameters (PI-QUAL v2), the longitudinal assessment system PRECISE v2, and the main radiological triggers for re-biopsy and multidisciplinary discussion were analyzed.
RESULTS: Baseline mpMRI improves candidate selection and reduces the risk of underestimating clinically significant disease. During follow-up, radiological progression shows a sensitivity of approximately 59% and specificity of approximately 75%, with a high negative predictive value (81-88%) but moderate positive predictive value. PRECISE v2 introduces updated categories, mandatory integration of image quality assessment, and systematic comparison with prior examinations, thereby improving reproducibility and comparability.
CONCLUSIONS: The standardized integration of mpMRI, PI-QUAL v2, and PRECISE v2 enables more structured patient monitoring and supports multidisciplinary decision-making. However, mpMRI does not replace scheduled biopsies. The implementation of radiomics and artificial intelligence may further enhance the objectivity and effectiveness of active surveillance.
引用
- Testini, Eusebi, Sortino, et al. The role of magnetic resonance imaging in the active surveillance of prostate cancer: state of the art. Abdom Radiol (NY). 2026. PMID: 42599455. doi:10.1007/s00261-026-05738-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。